Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$191.17 - $325.63 $18.5 Million - $31.6 Million
-96,899 Reduced 70.0%
41,538 $13.5 Million
Q4 2023

Feb 14, 2024

SELL
$160.99 - $215.69 $13.1 Million - $17.6 Million
-81,416 Reduced 37.03%
138,437 $26.4 Million
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $8.4 Million - $12.3 Million
-43,239 Reduced 16.43%
219,853 $43.8 Million
Q2 2023

Aug 14, 2023

SELL
$223.05 - $302.68 $46.5 Million - $63 Million
-208,291 Reduced 44.19%
263,092 $75.1 Million
Q1 2023

May 15, 2023

SELL
$175.41 - $217.92 $49.9 Million - $62 Million
-284,625 Reduced 37.65%
471,383 $102 Million
Q4 2022

Feb 21, 2023

SELL
$204.38 - $296.82 $42.7 Million - $62 Million
-208,801 Reduced 21.64%
756,008 $155 Million
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $29.7 Million - $47.3 Million
-152,328 Reduced 13.64%
964,809 $268 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $27 Million - $49.9 Million
232,570 Added 26.29%
1,117,137 $214 Million
Q1 2022

May 16, 2022

BUY
$127.96 - $207.36 $43.9 Million - $71.2 Million
343,144 Added 63.38%
884,567 $183 Million
Q4 2021

Feb 11, 2022

BUY
$165.13 - $241.83 $7.52 Million - $11 Million
45,553 Added 9.19%
541,423 $96.6 Million
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $21.3 Million - $30.7 Million
-130,152 Reduced 20.79%
495,870 $102 Million
Q2 2021

Aug 13, 2021

SELL
$131.45 - $201.49 $2.43 Million - $3.72 Million
-18,476 Reduced 2.87%
626,022 $119 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $3.69 Million - $5.65 Million
-39,760 Reduced 5.81%
644,498 $84 Million
Q4 2020

Feb 16, 2021

BUY
$67.44 - $103.72 $7.85 Million - $12.1 Million
116,410 Added 20.5%
684,258 $71 Million
Q3 2020

Nov 13, 2020

BUY
$42.79 - $75.8 $447,027 - $791,882
10,447 Added 1.87%
567,848 $43 Million
Q2 2020

Aug 11, 2020

BUY
$27.25 - $47.53 $15.2 Million - $26.5 Million
557,401 New
557,401 $26.4 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.